TickerFacts.

Q/C Technologies, Inc. (QCLS): R&D Expense

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2017-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$3.47M
Year ended 2025-12-31
$1.80M
Trailing 12 months to 2026-06-30
-27.4%
3-year compound annual growth
+7.1%
5-year compound annual growth
$9.07M2013-12-31: $1.01M2014-12-31: $916.3K2015-12-31: $1.41M2016-12-31: $1.19M2017-12-31: $1.26M2018-12-31: $1.06M2019-12-31: $276.8K2020-12-31: $2.47M2021-12-31: $6.75M2022-12-31: $9.07M2023-12-31: $7.87M2024-12-31: $3.44M2025-12-31: $3.47M$3.47M
2013-12-31 R&D Expense (USD) 2025-12-31
Period endedR&D ExpenseChange YoYSource filing
2025-12-31$3.47M+0.9%2026-04-15, From 2025-01-01
2024-12-31$3.44M-56.3%2026-04-15, From 2024-01-01
2023-12-31$7.87M-13.2%2025-04-11, From 2023-01-01
2022-12-31$9.07M+34.4%2024-04-01, From 2022-01-01
2021-12-31$6.75M+173.4%2023-03-31, From 2021-01-01
2020-12-31$2.47M+791.3%2022-03-31, From 2020-01-01
2019-12-31$276.8K-74.0%2020-03-25, From 2019-01-01
2018-12-31$1.06M-15.6%2020-03-25, From 2018-01-01
2017-12-31$1.26Mn/c2019-04-01, From 2017-01-01
2016-12-31$1.19M-15.5%2018-07-13, From 2016-01-01
2015-12-31$1.41M+53.5%2017-04-11, From 2015-01-01
2014-12-31$916.3K-9.0%2016-03-30, From 2014-01-01
2013-12-31$1.01Mn/a2015-03-23, From 2013-01-01

R&D Expense at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
Q/C Technologies, Inc. (QCLS)2025-12-31$3.47M+0.9%
Achieve Life Sciences, Inc. (ACHV)2024-12-31$22.82M+44.3%
Immucell Corp (ICCC)2025-12-31$3.04M-22.0%
Anbio Biotechnology (NNNN)2025-12-31$201.3K-55.7%
Insight Molecular Diagnostics Inc. (IMDX)2025-12-31$15.90M+61.6%
Alpha Teknova, Inc. (TKNO)2025-12-31$2.20M-20.4%
Cardio Diagnostics Holdings, Inc. (CDIO)2025-12-31$641.2K+181.3%
Volitionrx Ltd (VNRX)2025-12-31$10.08M-30.0%
Biomerica Inc (BMRA)2026-05-31$788.0K-23.0%

Compare QCLS, ACHV, ICCC, NNNN side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗